Image

C1D06698

Study Type Demographic Gender Age Location Compensation
Healthy Healthy; non-smokers for at least the past 1 year Males & Females 18 to 55 years Mississauga, ON Up to $10,160
Study Details

Study Purpose

The purpose of this study is to compare the amount of active test drug (T) in your blood to the reference product (R), after multiple doses, under fasting conditions.

Study Duration

Two periods, spaced 12 days apart, with a confinement of 10 days per period; No return visits; 1 end of study visit 4 months after the last dose in Period 2

Study Schedule

General Screening

NA

Medical Screening

October 24, 26, 27

Study Visit(s)

COHORT 1 - Visit Period 1 Period 2
Check-in (start time 1:00 pm) 04 Nov 2026 24 Nov 2026
Dosing (start time 7:30 am) 05 Nov 2026 to 13 Nov 2026 25 Nov 2026 to 03 Dec 2026
Check-out (start time 7:30 am) 14 Nov 26 04 Dec 26
Return End of Study Visit ECHO NA TDB 4 months after last Period 2 dose


COHORT 2 - Visit Period 1 Period 2
Check-in (Start time 1:00 pm) 06 Nov 2026 26 Nov 2026
Dosing (Start time 07:30 am) 07 Nov 2026 to 15 Nov 2026 27 Nov 2026 to 05 Dec 2026
Check-out (Start time 07:30 am) 16 Nov 2026 06 Dec 2026
Return - End of study Visit ECHO NA TDB 4 months after last Period 2 dose

Follow-Up Visit(s)

See study visits.

Other Notes

Bring Valid Photo ID.